Biotechnology Stocks II Performance Guide: Stoke Therapeutics, Inc. (STOK)
STOK has no dividends.
Table and Chart of STOK Performance
See what a $1,000 investment in STOK is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| STOK Returns | |
|---|---|
| Start Date | Jul-31-2019 |
| Start Price | $24.64 |
| End Date | Jul-26-2024 |
| End Price | $15.86 |
| # Prices | 61 |
| Min Date | Nov-30-2023 |
| Min Price | $3.79 |
| Max Date | Dec-31-2020 |
| Max Price | $61.93 |
| Total Return | -35.63% |
| Annualized Return | -8.30% |
| Current Value of $1,000 Purchase | $644 |
| Number Returns | 1,830 |
| Average Return | -28.73% |
| Number Profitable Returns | 397 |
| Percent Profitable Returns | 21.69% |
| Number Unprofitable Returns | 1,433 |
| Percent Unprofitable Returns | 78.31% |
| Profitable to Unprofitable Returns Ratio | 0.28 |
| STOK Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $758,877,000 |
| Beta | 0.863 | Price to Sales | 75.43 |
| Earnings per Share | $-2.4200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.15 |
| PRICE DATA | |
| 52 Week High | $17.58 |
| 52 Week Low | $3.35 |
| Analyst Target Price | $23.5 |
| 50-Day Moving Average | $14.48 |
| 200-Day Moving Average | $8.6 |
| FINANCIAL DATA | |
| Revenue per Share | $0.175 |
| Revenue | $7,844,000 |
| Profit Margin | 0% |
| Return on Equity | -61.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
STOK Compare Returns with S&P 500
STOK Trendline Chart
STOK Moving Average Chart
STOK Stock Return Map - See Patterns of Gains and Losses
STOK Stock Returns/Purchase Dates